CX3CL1, an immunoregulatory gene that is highly expressed in inflammatory ccRCC, provides a tool that enables individualized treatment of ccRCC (Wang et al., 2021). This evidence concerns the gene CX3CL1 and nonpapillary renal cell carcinoma.